Nail Paksoy

tahun pengalaman

Nail Paksoy

Spesialisasi: Oncologist/mammologist
15 tahun pengalaman
akreditasi:
Berbahasa:
English, Turkish
Konsultasi online: tersedia
Tempat kerja: Turquia, Istambul, Medipol Bahçelievler Hospital
Assoc. Prof. Nail Paksoy berspesialisasi dalam pengobatan kanker kandung kemih di Rumah Sakit Medipol Bahçelievler, dengan membawa pengalaman penelitian dan uji klinis yang luas.
- Tersertifikasi Dewan ESMO dalam Onkologi Medis
- Berpartisipasi dalam berbagai uji klinis internasional untuk karsinoma urotelial
- Menerbitkan penelitian tentang faktor prognostik pada kanker kandung kemih metastatik
- Menyelesaikan pelatihan Fellowship di Institut Onkologi Universitas Istanbul

Konsultasi online dengan Nail Paksoy

Mudah dan praktis

100% aman dan rahasia

Harga berdasarkan permintaan

4.5

Skor baik

2 ulasan pasien terverifikasi

1 bintang

2 bintang

3 bintang

4 bintang

50%

5 bintang

50%

Ulasan pasien

Tentang klinik Medipol Bahçelievler Hospital

Dokter ini belum memiliki ulasan, namun Anda dapat melihat ulasan untuk klinik tempat ia bekerja.

Kepercayaan Anda adalah prioritas utama kami

Kami menghargai kepercayaan Anda di atas segalanya, jadi klinik tidak bisa membayar untuk mengubah atau menghapus ulasan.

Pelajari lebih lanjut tentang ulasan.

1-2 dari 2 ulasan

Anonim • Hidrokel

Estados Unidos da América

25 Jul 2024

Ulasan terverifikasi.

kelompok dokter terbaik dan bermanfaat

tim medis juga merupakan kelompok dokter terbaik dan sangat membantu di rumah sakit serta merupakan rumah sakit internasional yang baik di Istanbul, Turki terima kasih banyak Ashley Kesete ————————-

1. orang-orang yang bekerja di rumah sakit mereka sangat membantu dan mereka adalah orang-orang yang baik

tidak masalah Saya sangat menyukai dokter dan tim medis di rumah sakit

Tentang layanan bookimed

Saya hanya ingin mengucapkan terima kasih atas bantuan Anda dan semoga Allah memberkati Anda dan keluarga Anda.

Marksmore Madzima • Hidrokel

Reino Unido

11 Mar 2024

Ulasan terverifikasi.

Konsultan tersebut sangat cemerlang

Konsultan sangat cemerlang. Tersedia untuk menjawab pertanyaan apapun. Tim medis tepat waktu dan mengetahui pekerjaan mereka. Satu-satunya kendala adalah beberapa perawat.

Sikap pria di Hotel. Resepsionis saat saya tiba pada hari kedatangan. Mereka mengusir saya dan saya harus mencari akomodasi di tempat lain. Sangat tidak profesional dalam pendekatan mereka.

Layanan dokter

Lihat lagi

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Sertifikasi & akreditasi

ESMO Board Certification in Medical Oncology

Kualifikasi

Assoc. Prof. Nail Paksoy is an oncologist at Medipol Bahçelievler University Hospital in Turkey. He holds ESMO Board Certification in medical oncology. Dr. Paksoy specializes in systemic therapies, clinical trials, and tumor management.

Specialization and Oncology Approach

Dr. Paksoy treats solid tumors and hematological malignancies. He treats cases of lung, breast, prostate, and gastrointestinal cancers. The doctor also treats conditions like Ewing’s sarcoma and Kaposi sarcoma. He applies protocols including:

Targeted therapy for lung and breast cancer
Immunotherapy using agents like Keytruda (Pembrolizumab)
Lutetium-177 and peptide receptor radionuclide therapy (PRRT) – a molecular therapy that targets specific receptors on cancer cells to deliver radiation
Chemotherapy for stage 4 cancers
Hormone therapy for reproductive system tumors

Clinical Trials and Research Focus

Dr. Paksoy serves as a subinvestigator in international clinical trials. He has worked with pharmaceutical companies like ROCHE, Pfizer, and Bayer. His trial experience includes testing Atezolizumab for breast cancer and Lorlatinib for lung cancer. Additionally, he researches treatments for endometrial and ovarian cancers. His clinical work informs his approach to treatment-resistant tumors.

Work Experience

2023–present – Associate Professor of Medical Oncology – Medipol Bahçelievler Private Hospital, Istanbul
2022–2023 – Medical Oncology Specialist – Tekirdag City Hospital, Turkey
2018–2022 – Medical Oncology Fellow – Istanbul University Oncology Institute
2017–2018 – Allergy and Immunology Fellow – Istanbul University Istanbul Medical Faculty
06/2017–10/2017 – Internal Medicine – Istanbul Gaziosmanpasa Taksim Training and Research Hospital
2012–2017 – Internal Medicine Department – Istanbul University Cerrahpaşa Medical Faculty
2011–2012 – General Medicine – Erzurum Koprukoyu State Hospital, Turkey

Education and Advanced Training

2023 – Medical Oncology Assoc. Prof. – Istanbul Medipol University, Turkey
2022 – ESMO Board Certification in Medical Oncology – Paris, France
2018–2022 – Medical Oncology Fellowship – Istanbul University Oncology Institute
2017–2018 – Allergy-Immunology Fellowship – Istanbul University Istanbul Medical Faculty
2012–2017 – Internal Medicine Residency – Istanbul University Cerrahpaşa Medical Faculty
2005–2011 – Medical Degree – Sivas Cumhuriyet University Medical Faculty, Turkey

Publications and Scientific Recognition

Dr. Paksoy has authored papers in journals indexed by SCI and SSCI. He frequently presents at ASCO and ESMO congresses. His research appears in Medicine, European Urology Focus, and the Journal of Chemotherapy. Notable publications include:

"Weekly Paclitaxel in Classic Kaposi Sarcoma" – Medicine
"Carboplatin Desensitization in Ovarian Carcinoma" – Medicine
"High-Dose Chemotherapy for Ewing’s Sarcoma" – Medicine
"Real-Life Efficacy of Osimertinib in Advanced NSCLC" – Journal of Cancer Research and Clinical Oncology
"Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients" – Turkish Journal of Oncology
"Multidrug Refractory TFE3(+) Renal Cell Carcinoma" – Journal of Oncology Pharmacy Practice
"Atezolizumab in Metastatic Urothelial Carcinoma" – European Urology Focus